Evidence map›Paper›PMID 30616455›Full record

ArticleJournal of the American Heart Association2019

Adherence to Statin Therapy Among US Adults Between 2007 and 2014.

Lisandro D Colantonio, Robert S Rosenson, Luqin Deng, Keri L Monda, Yuling Dai, Michael E Farkouh, Monika M Safford, Kiran Philip, Katherine E Mues, Paul Muntner

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Association between Exposure to Statin Choice and Adherence to Statins: An Observational Cohort Study.Medical decision making : an international journal of the Society for Medical Decision Making · 2025
    Observational
  11. Article
  12. Article
  13. Article
  14. Are statin side effects dependent on sex? A narrative review.Przeglad menopauzalny = Menopause review · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lisandro D Colantonio1 Department of Epidemiology School of Public Health University of Alabama at Birmingham AL.
Robert S Rosenson2 Mount Sinai Heart Icahn School of Medicine at Mount Sinai New York NY.
Luqin Deng1 Department of Epidemiology School of Public Health University of Alabama at Birmingham AL.
Keri L Monda3 Center for Observational Research Amgen Inc. Thousand Oaks CA.
Yuling Dai1 Department of Epidemiology School of Public Health University of Alabama at Birmingham AL.
Michael E Farkouh4 Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre of Excellence University of Toronto Ontario Canada.
Monika M Safford5 Department of Medicine Weill Cornell Medical College New York NY.
Kiran Philip6 Medical Affairs Amgen Inc. Thousand Oaks CA.
Katherine E Mues3 Center for Observational Research Amgen Inc. Thousand Oaks CA.
Paul Muntner1 Department of Epidemiology School of Public Health University of Alabama at Birmingham AL.

Funding

Zevalin Radioimmunotherapy Using a Modified TreatmentM01RR000032 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RICH, ROBERT R. · 1985 to 2008
$23.6M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
NCRR NIH HHS M01 RR000032NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

Background Prior studies suggest that persistence with and adherence to statin therapy is low. Interventions to improve statin persistence and adherence have been developed over the past decade. Methods and Results This was a retrospective cohort study of adults aged ≥21 y with commercial or government health insurance in the MarketScan (Truven Health Analytics) and Medicare databases who initiated statins in 2007-2014 and (1) started treatment after a myocardial infarction (n=201 573), (2) had diabetes mellitus but without coronary heart disease (CHD; n=610 049), or (3) did not have CHD or diabetes mellitus (n=2 244 868). Persistence with (ie, not discontinuing treatment) and high adherence to statin therapy were assessed using pharmacy fills in the year following treatment initiation. In 2007 and 2014, the proportions of patients persistent with statin therapy were 78.1% and 79.1%, respectively, among those initiating treatment following myocardial infarction; 66.5% and 67.3%, respectively, for those with diabetes mellitus but without CHD; and 64.3% and 63.9%, respectively, for those without CHD or diabetes mellitus. Between 2007 and 2014, high adherence to statin therapy increased from 57.9% to 63.8% among patients initiating treatment following myocardial infarction and from 34.9% to 37.6% among those with diabetes mellitus but without CHD (each P

Indexed as

Drug MonitoringAdultAgedAged, 80 and overAge DistributionAge FactorsCardiovascular DiseasesFemaleFollow-Up StudiesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedPrognosisRetrospective StudiesSecondary PreventionHydroxymethylglutaryl-CoA Reductase Inhibitorsmedication adherencestatin therapy

Identifiers

PMID30616455
PMCPMC6405715

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.